Susquehanna International Group Ltd. Astrazeneca PLC Transaction History

Susquehanna International Group Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$61.03 - $69.57 $1.11 Million - $1.26 Million	18,143 Added 196.76%	27,364 $1.85 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $149,711 - $167,588	2,419 Added 35.56%	9,221 $621,000
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $441,109 - $487,703	6,802 New	6,802 $460,000
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $498,575 - $575,539	-10,572 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $512,953 - $613,387	10,572 New	10,572 $528,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group Ltd. with notifications on news.